Astellas Pharma Inc. (ALPMY)
USD 9.65
(-0.31%)
USD 9.65
(-0.31%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1603.67 Billion | 1518.61 Billion | 1296.16 Billion | 1249.52 Billion | 1300.84 Billion | 1306.34 Billion |
| Cost of Revenue | 391.3 Billion | 326.78 Billion | 281.29 Billion | 269.82 Billion | 297.9 Billion | 327.26 Billion |
| Gross Profit | 1212.36 Billion | 1191.83 Billion | 1014.87 Billion | 979.7 Billion | 1002.94 Billion | 979.08 Billion |
| Operating Expenses | 1034.29 Billion | 906.4 Billion | 794.85 Billion | 728.8 Billion | 723.52 Billion | 698.94 Billion |
| Selling, General and Administrative Expenses | 740.11 Billion | 630.27 Billion | 548.84 Billion | 504.31 Billion | 499.29 Billion | 490.26 Billion |
| Research and Development Expenses | 294.18 Billion | 276.12 Billion | 246.01 Billion | 224.48 Billion | 224.22 Billion | 208.68 Billion |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1425.6 Billion | 1233.18 Billion | 1076.14 Billion | 998.63 Billion | 1021.42 Billion | 1026.2 Billion |
| Operating Income | 25.51 Billion | 285.43 Billion | 220.02 Billion | 250.89 Billion | 279.41 Billion | 280.14 Billion |
| Interest Expense | 12 Billion | 3.62 Billion | 4.94 Billion | 2.33 Billion | 3 Billion | 1.3 Billion |
| Income Tax Expense | 7.92 Billion | 33.64 Billion | 32.8 Billion | 24.73 Billion | 49.93 Billion | 26.7 Billion |
| Earnings before Tax | 24.96 Billion | 131.1 Billion | 156.39 Billion | 144.84 Billion | 247.01 Billion | 248.96 Billion |
| Net Income | 17.04 Billion | 98.71 Billion | 124.08 Billion | 120.58 Billion | 195.41 Billion | 222.26 Billion |
| Earnings Per Share Basic | 9.47 | 54.24 | 67.08 | 64.93 | 104.15 | 115.05 |
| Earnings Per Share Diluted | 9.47 | 54.09 | 67.05 | 64.90 | 104.08 | 114.94 |
| Weighted Average Shares Outstanding | 1.79 Billion | 1.82 Billion | 1.84 Billion | 1.85 Billion | 1.87 Billion | 1.93 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.79 Billion | 1.82 Billion | 1.85 Billion | 1.85 Billion | 1.87 Billion | 1.93 Billion |
| Gross Margin | 0.76 | 0.78 | 0.78 | 0.78 | 0.77 | 0.75 |
| EBIT Margin | 0.12 | 0.26 | 0.23 | 0.26 | 0.27 | 0.26 |
| Profit Margin | 0.01 | 0.07 | 0.10 | 0.10 | 0.15 | 0.17 |
| EBITDA | 194.81 Billion | 246.87 Billion | 241.51 Billion | 220.31 Billion | 314.75 Billion | 313.72 Billion |
| Earnings Before Tax Margin | 0.02 | 0.19 | 0.17 | 0.20 | 0.21 | 0.21 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 414.6 Billion | 1603.67 Billion | 421.93 Billion | 392.14 Billion | 374.99 Billion | 1518.61 Billion |
| Cost of Revenue | 105.87 Billion | 391.3 Billion | 108.33 Billion | 99.07 Billion | 78.01 Billion | 326.78 Billion |
| Gross Profit | 308.72 Billion | 1212.36 Billion | 313.59 Billion | 293.07 Billion | 296.97 Billion | 1191.83 Billion |
| Operating Expenses | 271 Billion | 1034.29 Billion | 273.88 Billion | 256.63 Billion | 232.77 Billion | 906.4 Billion |
| Selling, General and Administrative Expenses | 193.14 Billion | - | 199.49 Billion | 179.28 Billion | 168.18 Billion | - |
| Research and Development Expenses | 77.85 Billion | - | 74.38 Billion | 77.35 Billion | 64.59 Billion | - |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 376.87 Billion | 1425.6 Billion | 382.22 Billion | 355.71 Billion | 310.78 Billion | 1233.18 Billion |
| Operating Income | 37.72 Billion | 178.07 Billion | 39.7 Billion | 36.43 Billion | 64.2 Billion | 285.43 Billion |
| Interest Expense | 4.18 Billion | 12 Billion | 2.83 Billion | 2.26 Billion | 2.72 Billion | 3.62 Billion |
| Income Tax Expense | -15.38 Billion | 7.92 Billion | 2.8 Billion | 6.78 Billion | 13.72 Billion | 33.64 Billion |
| Earnings before Tax | -45.95 Billion | 28.13 Billion | 17.53 Billion | 6.25 Billion | 46.16 Billion | 131.1 Billion |
| Net Income | -33.27 Billion | 17.04 Billion | 14.51 Billion | -1.45 Billion | 33.12 Billion | 98.71 Billion |
| Earnings Per Share Basic | -18.56 | - | 8.09 | -0.81 | 18.46 | - |
| Earnings Per Share Diluted | -18.56 | - | 8.06 | -0.81 | 18.42 | - |
| Weighted Average Shares Outstanding | 1.79 Billion | 1.79 Billion | 1.79 Billion | 1.79 Billion | 1.79 Billion | 1.82 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.79 Billion | 1.79 Billion | 1.8 Billion | 1.79 Billion | 1.79 Billion | 1.82 Billion |
| Gross Margin | 0.74 | 0.76 | 0.74 | 0.75 | 0.79 | 0.78 |
| EBIT Margin | 0.21 | - | 0.21 | 0.19 | 0.23 | - |
| Profit Margin | -0.08 | 0.01 | 0.03 | -0.00 | 0.09 | 0.07 |
| EBITDA | 86.36 Billion | - | 86.69 Billion | 75.4 Billion | 87.44 Billion | - |
| Earnings Before Tax Margin | 0.09 | 0.11 | 0.09 | 0.09 | 0.17 | 0.19 |
6568
CTPCF
ZAM
SMC
MAIN
HYHDF